How I'd invest $10,000 today

This is how I'd invest $10,000 today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The prices of shares are always going up and down thanks to an ever-changing group of buyers and sellers.

This liquidity can turn a share from expensive to good value in the space of a few days or weeks.

Indeed, over the last couple of months the share market has fallen by a sizeable amount because of rising interest & bond rates.

If I were lucky enough to be given $10,000 to invest, this is how I'd do it:

Challenger Ltd (ASX: CGF)

Australia's leading annuity business' share price has fallen substantially during 2018 due to the rising interest rates, along with the CEO announcing his retirement recently.

I think the current share price is a very fair price to buy shares because it's trading at under 14x FY19's estimated earnings. This seems cheap for a business that is growing underlying profit by at least high single digits every year.

I am particularly drawn to Challenger because it has ultra-long-term growth potential. Its main client base is the retiree population, which is projected to grow by 40% over the next 10 years and by 70% over the next 20 years.

Combined with its current grossed-up dividend yield of 5.3%, it looks like a long-term market-beater to me at this price.

Paragon Care Ltd (ASX: PGC)

Paragon Care is a medical device, equipment and product distributor which it sells through a single online platform to customers like hospitals and aged care facilities.

I like that it is a generalised play on the healthcare industry which is both defensive and a growth sector. People don't get sick according to economic cycles, but we will pay what it takes to remain alive healthy and healthy.

The more products that Paragon can sell to its customers the bigger its economies of scale become.

Paragon has increased its dividend each year since 2013, it's trading at under 10x earnings with a grossed-up dividend yield of 6.7%.

MNF Group Ltd (ASX: MNF)

MNF is a leading voice over internet protocol (VoIP) business with many large private and public clients including Skype and Uber.

MNF is generating good organic growth, has plans to expand in Singapore and is growing an over-50s regional telco brand called Pennytel. It has several growth levers.

Its share price has been hurt along with most other growth shares in recent times, however the market seemed unimpressed with its profit guidance for the next two years suggesting earnings per share (EPS) could grow by at least 25% by FY20.

MNF is trading at under 24x FY19's estimated earnings with a grossed-up dividend yield of 2.9%.

Vanguard FTSE Asia Ex Japan Shares Index ETF (ASX: VAE)

Asia is the fastest-growing region economically, particularly India and China. Some of the GDP numbers may be a tad inflated and some Asia businesses may not be the most honest on the planet, but it could be an unwise move to ignore the region entirely.

I'm not sure which country or which business is the best, so the right move could be simply to invest in an Asian index fund like this one offered by Vanguard.

You get exposure to 850 Asian companies based in China, Hong Kong, Taiwan and India, among other countries.

According to Vanguard, this index is growing earnings at more than 10% – twice the rate expected of ASX businesses this year. It also comes with a handy 2.9% dividend yield and is trading with a price/earnings ratio of under 11.

Foolish takeaway

These are four of my favourite growth share ideas right now. It's hard to pick a favourite, each has their own merits. If I had to narrow it down to two it would be Paragon and Challenger – I already own these two in my portfolio for the long-term, so I'd be topping up my holding.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited and Paragon Care Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited and MNF Group Limited. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »